Berger, David http://orcid.org/0000-0003-0705-6341
Hobi, Jan
Möller, Per W.
Haenggi, Matthias
Takala, Jukka
Jakob, Stephan M.
Article History
Received: 24 June 2020
Accepted: 29 September 2020
First Online: 7 October 2020
Ethics approval and consent to participate
: The study was approved by the animal protection committee of the canton of Bern (BE 71/14).
: Not applicable
: The Department of Intensive Care Medicine, University Hospital Bern, has, or has had in the past, research contracts with Orion Corporation, Abbott Nutrition International, B. Braun Medical AG, CSEM SA, Edwards Lifesciences Services GmbH, Kenta Biotech Ltd., Maquet Critical Care AB, and Omnicare Clinical Research AG and research and development/consulting contracts with Edwards Lifesciences SA, Maquet Critical Care AB, and Nestlé. The money was paid into a departmental fund; no author received personal financial gain.The Department of Intensive Care Medicine has received unrestricted educational grants from the following organizations for organizing a quarterly postgraduate educational symposium, the Berner Forum for Intensive Care (until 2015): Fresenius Kabi, gsk, MSD, Lilly, Baxter, astellas, AstraZeneca, B | Braun, CSL Behring, Maquet, Novartis, Covidien, Nycomed, Pierre Fabre Pharma AG (formerly known as RobaPharm), Pfizer, Orion Pharma, Bard Medica S.A., Abbott AG, and Anandic Medical Systems.The Department of Intensive Care Medicine has received unrestricted educational grants from the following organizations for organizing bi-annual postgraduate courses in the fields of critical care ultrasound, management of ECMO, and mechanical ventilation: Pierre Fabre Pharma AG (formerly known as RobaPharm), Pfizer AG, Bard Medica S.A., Abbott AG, Anandic Medical Systems, PanGas AG Healthcare, Orion Pharma, Bracco, Edwards Lifesciences AG, Hamilton Medical AG, Fresenius Kabi (Schweiz) AG, Getinge Group Maquet AG, Dräger Schweiz AG, and Teleflex Medical GmbH.Authors Berger, Hobi, Möller, Haenggi, and Jakob do not have any personal conflicts of interest. Dr. Takala has, after his retirement from the Department of Intensive Care Medicine in August 2018, provided paid consultancy services for the Medical Director and the Director of Technology and Innovation of the Inselspital, Bern University Hospital, and to Nestec SA.